[1] Macias R I R, Monte M J, Serrano M A, et al. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics[J]. Aging (Albany NY), 2021, 13(19): 23416-23434. [2] Zheng Y, Li Y, Feng J, et al. Cellular based immunotherapy for primary liver cancer[J]. J Exp Clin Cancer Res, 2021, 40(1): 250. [3] 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 传染病信息, 2020, 33(6): 481-500. [4] Hu M, Li M, Huang H, et al. Isolated cancer stem cells from human liver cancer: morphological and functional characteristics in primary culture[J]. Clin Transl Oncol, 2022, 24(1): 48-56. [5] Wege H, Schulze K, von Felden J, et al. Rare variants of primary liver cancer: fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas[J]. Eur J Med Genet, 2021, 64(11): 104313. [6] 王宗琰, 顾方明. 原发性肝癌术后复发的预防和治疗进展[J]. 肝胆胰外科杂志, 2022, 34(7): 394-398. [7] Hwang S, Song G W, Ahn C S, et al. Salvage living donor liver transplantation for hepatocellular carcinoma recurrence after hepatectomy: quantitative prediction using adv score[J]. J Hepatobiliary Pancreat Sci, 2021, 28(11): 1000-1013. [8] Hong S K, Jin X L, Suh S, et al. Different risk factors for early and late recurrence after curative resection of hepatocellular carcinoma[J]. World J Surg, 2022, 46(1): 197-206. [9] Shi H Y, Lee K T, Chiu C C, et al. 5-year recurrence prediction after hepatocellular carcinoma resection: deep learning vs. cox regression models[J]. Am J Cancer Res, 2022, 12(6): 2876-2890. [10] Ivanics T, Nelson W, Patel M S, et al. The toronto postliver transplantation hepatocellular carcinoma recurrence calculator: a machine learning approach[J]. Liver transpl, 2022, 28(4): 593-602. [11] Nevola R, Ruocco R, Criscuolo L, et al. Predictors of early and late hepatocellular carcinoma recurrence[J]. World J Gastroenterol, 2023, 29(8):1243-1260. [12] Healy M A, Choti M A. Hepatocellular carcinoma recurrence risk in the context of emerging therapies[J]. Ann Surg Oncol , 2022, 29(7): 4030-4032. [13] Liu Z, Liu Y, Zhang W, et al. Deep learning for prediction of hepatocellular carcinoma recurrence after resection or liver transplantation: a discovery and validation study[J]. Hepatol Int, 2022, 16(3): 577-589. [14] 夏晓露, 肖玉玲, 邱培, 等. 肝癌根治性切除术后复发的高危因素分析[J]. 实用癌症杂志, 2020, 35(11): 1875-1878. [15] 兆勇, 李井野. 老年肝癌根治性切除术后肝癌复发的高危因素分析[J]. 现代肿瘤医学, 2020, 28(21): 3745-3748. |